LEUKEMIA ACUTE MYELOID
Clinical trials for LEUKEMIA ACUTE MYELOID explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA ACUTE MYELOID trials appear
Sign up with your email to follow new studies for LEUKEMIA ACUTE MYELOID, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a targeted pill turn the tide against a bone marrow disorder?
Disease control OngoingThis trial is testing an oral drug called enasidenib (AG-221) in people with myelodysplastic syndrome (MDS) who have a specific genetic change called an IDH2 mutation. The drug is designed to block the mutated enzyme and help restore normal blood cell production. Participants rec…
Matched conditions: LEUKEMIA ACUTE MYELOID
Phase: PHASE2 • Sponsor: Groupe Francophone des Myelodysplasies • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope for tough blood cancers: experimental drug MGD024 enters human testing
Disease control OngoingThis early-stage study tests a new drug called MGD024 in people with certain blood cancers (like leukemia and lymphoma) that came back or didn't get better with standard treatments. The main goal is to find the safest dose and watch for side effects. About 130 adults will receive…
Matched conditions: LEUKEMIA ACUTE MYELOID
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated Jul 30, 2026 00:00 UTC